Health brief
Wartime Resilience and Clinical Frontiers
From fortified trauma helipads and frontline drill protocols to specialty hospital honors, Israel's healthcare system adapts under relentless pressure.
Health
A fatal pediatric amoeba case prompted health warnings across northern waterways — forcing public health monitors to rethink seasonal screening in warming freshwater basins.
BackgroundNaegleria fowleri is an extremely rare freshwater amoeba that causes primary amoebic meningoencephalitis, a central nervous system infection with a fatality rate exceeding 95%. The organism thrives in warm, stagnant fresh water during peak summer temperatures.
- The pediatric patient passed away at Rambam Health Care Campus in Haifa after laboratory testing confirmed primary amoebic meningoencephalitis contracted during a family vacation.
- Public health investigators traced the infection to Kursi Beach on the eastern shore of the Sea of Galilee, prompting immediate microbial sampling of shallow waters.
- The Health Ministry advised swimmers across northern freshwater sites to avoid submerging their heads, warning that warmer water temperatures accelerate amoebic proliferation.
Health
Jerusalem opened a specialized airborne medical hub — cutting critical trauma transport times from outlying regional corridors.
BackgroundEmergency ground transit through congested Jerusalem corridors frequently delays critical trauma patients reaching tertiary emergency departments. Regional air rescue operations require dedicated landing pads with direct coordination alongside national emergency services.
- The five-dunam facility was constructed by Hatzolah Air in collaboration with Magen David Adom, Brook Aviation, and Hadassah Medical Center to centralize regional dispatch.
- The base operates a Sikorsky S-76 helicopter configured with advanced airborne intensive care monitoring equipment, allowing critical interventions before hospital handoff.
- The flight hub expedites emergency medical evacuation for acute trauma, stroke, and cardiovascular cases from Beit Shemesh and the Jordan Valley, bypassing highway bottlenecks.
Health
Hadassah secured top global rankings across oncology and cardiology — proving Israeli tertiary centers can sustain cutting-edge specialty research through intense wartime clinical strain.
BackgroundHadassah operates two major tertiary university hospitals in Jerusalem at Ein Kerem and Mount Scopus. The organization treats regional complex trauma and conducts international clinical trials in precision oncology.
- Hadassah earned international recognition in cardiology for the seventh consecutive year and oncology for the sixth consecutive term, sustaining high clinical review scores.
- The institution was listed among the World's Best Smart Hospitals for integrating robotic surgical tools and clinical artificial intelligence into daily bedside workflows.
- Director General Dr. Yoram Weiss stated the achievement reflects staff dedication to clinical care despite severe wartime emergency mobilization and acute staffing constraints.
Health
Israel became the first non-Nordic country to commercialize Terclara — opening a non-systemic prescription route for patients who cannot tolerate liver-taxing oral antifungals.
BackgroundOnychomycosis is a stubborn fungal nail infection affecting tens of millions of adults globally. Standard oral antifungal treatments can cause systemic liver toxicity, driving clinical demand for effective topical alternatives.
- Commercial partner Padagis began distributing Terclara directly to dermatologists and community pharmacy networks across Israel, establishing immediate nationwide retail availability for patients.
- The launch follows formal safety and manufacturing batch clearance granted by the Ministry of Health's pharmaceutical division, clearing regulatory barriers for broader local adoption.
- The treatment provides a targeted topical alternative for patients unable to take oral systemic antifungal therapies due to liver toxicity risks or conflicting prescription regimens.
Health
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
